Business
Celanese produces engineered materials and acetyl-chain chemicals used across automotive, industrial, consumer and medical markets.
Celanese's revenue decline, large loss and negative operating margin showed severe chemical stress, while positive free cash flow provided a limited counterweight.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 7.1%Watch
- Profitability — The net loss narrowed from $1.542B to $1.165BOK
- Cash flow — Free cash flow grew 51.2% to $803M from $531MOK
- Margins — Operating margin contracted 123 bps to -8.24%Watch
- Accounting — Distress-range chemical year with positive cash flowWatch
- Insiders — 7 purchases and 0 salesOK
Where the revenue comes from
Fiscal 2025, as Celanese Corp reports it. History and quarterly detail are in the app.
- Engineered Materials$5.4B
- Acetyl Chain$4.2B
Leadership changes
From Celanese Corp's own filings, the day they're filed.
- Anne P. Noonan · director · appointmenteff. 2026-04-20
- Timothy Go · Directors · departureeff. 2026-02-27
- Scott Sutton · director · appointmenteff. 2025-03-01
Latest filings
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-06-10
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Celanese Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.